ProMetic Life Sciences, Inc.

ProMetic Life Sciences, Inc.

ProMetic Life Sciences, Inc.

Date Founded



440 Armand-Frappier Boulevard,Suite 300,Laval, QC H7V 4B4

Type of Company


Employees (Worldwide)



Medical Products & Equipment

Company Description

Prometic Life Sciences, Inc. is a biopharmaceutical corporation, which engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment offers prometic's core bioseparation technologies and products. The Plasma-derived Therapeutics segment provides efficient extraction and purification of therapeutic proteins from human plasma. The Small Molecule Therapeutics segment manufactures drug candidates such as PBI-4050, PBI-4547, and PBI-4425. The company was founded on October 14, 1994 and is headquartered in Quebec, Canada.

Contact Data
Trying to get in touch with decision makers at ProMetic Life Sciences, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Non-Independent Director

Chief Financial Officer

General Counsel

Chief Talent Officer

Chief Medical Officer

Chief Executive Officer, Prometic BioSciences Ltd

Chief Operating Officer-International

Chief Operating Officer, North America

Senior Director, Communications & Investor Relations

Senior Vice President of Product & Asia-Pacific Development Prometic BioTherapeutics Inc

Board of Directors

Chief Investment Officer & Managing Director at Thomvest Asset Management, Inc.

Chief Executive Officer at ProMetic Life Sciences, Inc.

Director at Thomvest Ventures, Inc.

Chief Financial Officer & Chief Accounting Officer at Zymeworks, Inc.

Former Attorney at Gowling Lafleur Henderson LLP

General Partner at Five Corners Capital, Inc.

Visiting Professor of Medicine at University of Edinburgh Medical School

Paths to ProMetic Life Sciences, Inc.
Potential Connections via
Relationship Science
ProMetic Life Sciences, Inc.
Recent Transactions
Details Hidden

ProMetic Life Sciences, Inc. issued CAD Common Shares - Bought Deal

Details Hidden

ProMetic Life Sciences, Inc. purchases Telesta Therapeutics, Inc.

Details Hidden

ProMetic Life Sciences, Inc. issued Common Stock

Transaction Advisors

Advised onProMetic Life Sciences, Inc. issued Common Stock


Advised onProMetic Life Sciences, Inc. issued Common Stock


Advised onProMetic Life Sciences, Inc. issued Common Stock

Executive Vice Chair & Managing Director, Institutional Fixed Income

Advised onProMetic Life Sciences, Inc. issued Common Stock


Advised onProMetic Life Sciences, Inc. issued Common Stock


Advised onProMetic Life Sciences, Inc. issued Common Stock


GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Net Profit
Debt TEV
Total Equity
Total Debt
Enterprise Value Sales
Three Year Compounded Annual Growth Rate Of Revenue
Five Year Compounded Annual Growth Rate Of Revenue
TEVNet Income
Details Hidden

AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands.

Details Hidden

Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications.Arriva's current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California.

The American Red Cross Social Interest | Washington, DC

The humanitarian mission of the American Red Cross connects us to people and communities across the nation and around the world. The common bonds of humanity and compassion unite us together, not just in the face of emergencies and disasters, but in helping our neighbors every day. Since being founded by Clara Barton in 1881, the Red Cross has been a consistent lifeline for people when they need us the most. The depth and breadth of our services – whenever and wherever they're called for – is unmatched by any organization in the world.

Omnio AB Biotechnology | Umeå, AC

Omnio AB is a Swedish private company located in Umeå that operates as biotechnical research and development company.

Roche Holding AG Pharmaceuticals - Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals - Ingelheim am Rhein, RP

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, which specializes in the manufacture of pharmaceutical products. It offers prescription drugs for human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, as well as for human immunodeficiency virus (HIV) infection and cancer. The company was founded on April 4, 1894 and is headquartered in Mannheim, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ProMetic Life Sciences, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ProMetic Life Sciences, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ProMetic Life Sciences, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15